Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2782 of 5804
-
New prosthetic grows with kids: no more frequent replacements?
Symptom relief CompletedAn immediate fit adjustable prosthetic system is being investigated for children. The age range being recruited is from 3 years up to 18 years old. Phase I of this study will involve developing a final prototype by conducting in-lab testing on children with limb loss. Phase II wi…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New drug tested for Long-Term safety in kids with rare muscle disease
Disease control ENROLLING_BY_INVITATIONThe purpose of this trial is to evaluate the long-term safety of efgartigimod IV and efgartigimod PH20 SC administered to participants with gMG in the antecedent studies, ARGX-113-2006 and ARGX-113-2207, respectively. Participants will receive efgartigimod IV or efgartigimod PH2…
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy aims to clear hepatitis b and d in 20-patient trial
Disease control CompletedPrimary objective: To evaluate the safety and tolerability of sequential administration of P1101 and anti-PD1 in patient with chronic hepatitis B or D infection Secondary objectives: 1. To explore HBsAg loss and kinetics during the study period 2. To assess the anti-viral effe…
Phase: PHASE1 • Sponsor: PharmaEssentia • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New glaucoma surgery under the microscope: 300 patients tracked for 2 years
Disease control OngoingThis observational study will enroll adults with open angle glaucoma (OAG) who had surgery to reduce intraocular pressure (IOP) using the CycloPen Micro-Interventional System. Consenting participants will be followed for 24 months after their surgery. Data regarding IOP, use of …
Sponsor: Iantrek, Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
VR goggles could replace pills for teen surgery anxiety
Symptom relief CompletedIn this randomized control trial, investigators would like to assess as primary objective the effectiveness of VR in anxiolysis via using State Trait Anxiety- Inventory test various time during the perioperative period with recorded physiologic data. As a secondary objective they…
Phase: NA • Sponsor: Semmelweis University • Aim: Symptom relief
Last updated Jun 26, 2026 14:40 UTC
-
Can a simple exercise program keep zuni elders on their feet?
Disease control CompletedFalls and fall-related injuries are major health risks in American Indian elders. The data showed 52 percent of Zuni elders reporting a fall during the past year, which is significantly higher than the US national average of one out of three adults older then 65 years. In partner…
Phase: NA • Sponsor: University of New Mexico • Aim: Disease control
Last updated Jun 26, 2026 12:58 UTC
-
New 3D MRI scan could replace needle test for liver patients
Diagnosis Recruiting nowHow to construct a novel, non-invasive, accurate, and convenient method to achieve prediction of hepatic venous pressure gradient (HVPG) is an important general problem in the management of portal hypertension in cirrhosis. We plan to compare the ability of three demensional-magn…
Sponsor: Shengjing Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
New drug XMT-1660 enters first human tests for Hard-to-Treat cancers
Disease control Recruiting nowA Study of Emi-Le in Participants with Solid Tumors
Phase: PHASE1, PHASE2 • Sponsor: Day One Biopharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Sleep disorder study could pave way for Parkinson's prevention
Knowledge-focused ENROLLING_BY_INVITATIONThis study will enroll participants with idiopathic REM sleep behavior disorder (RBD) and healthy controls for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Could a diabetes drug shield the brains of HIV patients?
Disease control CompletedMetabolic syndrome is a constellation of risk factors for cardiovascular disease and type 2 diabetes mellitus which frequently occur together. Data is emerging suggesting metabolic syndrome causes brain disease by contributing to blood vessel damage and inflammation. People livin…
Phase: PHASE2 • Sponsor: University of Stellenbosch • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Exercise program aims to protect hearts of black men on prostate cancer treatment
Disease control Recruiting nowThe purpose of this research is to determine whether a 16-week culturally tailored, technology-based, aerobic and resistance exercise intervention improves cardiovascular risk factors in Black men diagnosed with prostate cancer and are undergoing androgen deprivation therapy (ADT…
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug combo targets tough cancers in early trial
Disease control Recruiting nowThis is a first-in-human, Phase 1/2, open-label, study designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of Mavrostobart (PT199) alone and in combination with a PD-1 inhibitor or chemotherapy.
Phase: PHASE1, PHASE2 • Sponsor: Phanes Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Fatty liver drug shows promise in small trial
Disease control CompletedNonalcoholic fatty liver disease (NAFLD), fatty infiltration of the liver in the absence of alcohol use, is an increasingly recognized complication of obesity, with prevalence estimates of about 30% of individuals in the United States. A subset of these will develop progressive d…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could a nerve drug ease Parkinson's gut troubles?
Symptom relief Recruiting nowConstipation is a common and debilitating non-motor symptom of Parkinson disease (PD) that often precedes the onset of classic motor symptoms by decades. There is no standardized algorithm for managing constipation in this patient population, nor are there dedicated treatments. S…
Phase: PHASE2 • Sponsor: University of Vermont Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Four sessions at home may tame pelvic pain without pills
Symptom relief Recruiting nowThe EPPIC (Easing Pelvic Pain Interventions Clinical Research Program) study evaluates an ultra-brief, 4 session cognitive behavioral pain treatment transdiagnostic in design for urologic chronic pain syndrome (UCPPS) with clinical and practical advantages over existing behaviora…
Phase: NA • Sponsor: State University of New York at Buffalo • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
New nerve block may ease pain after heart surgery
Symptom relief CompletedCardiac surgery is a source of severe post operative pain witch can cause major respiratory complications due to non optimal post operative rehabilitation. Multimodal analgesia provides acceptable pain control , but does not seem sufficient during coughing or mobilization. The u…
Phase: NA • Sponsor: Institute Arnault Tzanck, France • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Robot-Assisted weight loss surgery under the microscope
Knowledge-focused CompletedWith increased prevalence of obesity in the general population over the past 30 years, researchers have been focused on the development of new treatment options to achieve long-lasting weight loss. In 1991, the National Institutes of Health Conference Statement on Gastrointestina…
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
New cocktail aims to starve pancreatic tumors
Disease control CompletedThis phase I trial tests the safety, side effects, and best dose of calaspargase pegol-mknl in combination with cobimetinib in treating patients with pancreatic cancer that has spread to nearby tissue or lymph nodes (locally advanced) or has spread to other places in the body (me…
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug combo tested for tough breast cancer
Disease control CompletedThe purpose of this study was to determine the safety of alpelisib plus fulvestrant in men and post-menopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, advanced or metastatic breast cancer (aBC) with a PIK3CA mutation, w…
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can a natural compound ease rheumatoid arthritis?
Disease control CompletedThis is a phase 2 study to determine 2-HOBA's tolerability, safety, and effect on isoLG-adducts in patients with rheumatoid arthritis (RA) patients. Up to 32 subjects will be randomized to 750mg 2-HOBA or matching placebo three times a day for 4 weeks. As primary outcome measure…
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC